Literature DB >> 30850428

The PlyB Endolysin of Bacteriophage vB_BanS_Bcp1 Exhibits Broad-Spectrum Bactericidal Activity against Bacillus cereus Sensu Lato Isolates.

Raymond Schuch1, Adam J Pelzek1, Daniel C Nelson1, Vincent A Fischetti2.   

Abstract

Lytic bacteriophages (or phages) drive bacterial mortality by elaborating exquisite abilities to bind, breach, and destroy bacterial cell membranes and subjugate critical bacterial cell functions. These antimicrobial activities make phages ideal candidates to serve as, or provide sources of, biological control measures for bacterial pathogens. In this study, we isolated the Myoviridae phage vB_BanS_Bcp1 (here referred to as Bcp1) from landfill soil, using a Bacillus anthracis host. The antimicrobial activities of both Bcp1 and its encoded endolysin, PlyB, were examined across different B. cereus sensu lato group species, including B. cereus sensu stricto, Bacillus thuringiensis, and Bacillus anthracis, with pathogenic potential in humans and multiple different uses in biotechnological applications. The Bcp1 phage infected only a subset (11 to 66%) of each B. cereus sensu lato species group tested. In contrast, functional analysis of purified PlyB revealed a potent bacteriolytic activity against all B. cereus sensu lato isolates tested (n = 79). PlyB was, furthermore, active across broad temperature, pH, and salt ranges, refractory to the development of resistance, bactericidal as a single agent, and synergistic with a second endolysin, PlyG. To confirm the potential for PlyB as an antimicrobial agent, we demonstrated the efficacy of a single intravenous treatment with PlyB alone or combination with PlyG in a murine model of lethal B. anthracis infection. Overall, our findings show exciting potential for the Bcp1 bacteriophage and the PlyB endolysin as potential new additions to the antimicrobial armamentarium.IMPORTANCE Organisms of the Bacillus cereus sensu lato lineage are ubiquitous in the environment and are responsible for toxin-mediated infections ranging from severe food poisoning (B. cereus sensu stricto) to anthrax (Bacillus anthracis). The increasing incidence of many of these infections, combined with the specter of antibiotic resistance, has created a need for novel antimicrobials with potent activity, including bacteriophages (or phages) and phage-encoded products (i.e., endolysins). In this study, we describe a broadly infective phage, Bcp1, and its encoded endolysin, PlyB, which exhibited a rapidly bacteriolytic effect against all B. cereus sensu lato isolates tested with no evidence of evolving resistance. Importantly, PlyB was highly efficacious in a mouse model of lethal bacteremia with B. anthracis Both the Bcp1 phage and the PlyB endolysin represent novel mechanisms of action compared to antibiotics, with potential applications to address the evolving problem of antimicrobial resistance.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Bacillus anthracis; Bacillus cereus; bacteriophage; endolysin

Mesh:

Substances:

Year:  2019        PMID: 30850428      PMCID: PMC6495760          DOI: 10.1128/AEM.00003-19

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  60 in total

Review 1.  Endolysins as antimicrobials.

Authors:  Daniel C Nelson; Mathias Schmelcher; Lorena Rodriguez-Rubio; Jochen Klumpp; David G Pritchard; Shengli Dong; David M Donovan
Journal:  Adv Virus Res       Date:  2012       Impact factor: 9.937

2.  Rapid multiplex detection and differentiation of Listeria cells by use of fluorescent phage endolysin cell wall binding domains.

Authors:  Mathias Schmelcher; Tatiana Shabarova; Marcel R Eugster; Fritz Eichenseher; Vincent S Tchang; Manuel Banz; Martin J Loessner
Journal:  Appl Environ Microbiol       Date:  2010-07-09       Impact factor: 4.792

3.  The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis.

Authors:  Corrine J Porter; Raymond Schuch; Adam J Pelzek; Ashley M Buckle; Sheena McGowan; Matthew C J Wilce; Jamie Rossjohn; Ryann Russell; Daniel Nelson; Vincent A Fischetti; James C Whisstock
Journal:  J Mol Biol       Date:  2006-11-18       Impact factor: 5.469

4.  'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.

Authors:  Lorena Rodríguez-Rubio; Wai-Ling Chang; Diana Gutiérrez; Rob Lavigne; Beatriz Martínez; Ana Rodríguez; Sander K Govers; Abram Aertsen; Christine Hirl; Manfred Biebl; Yves Briers; Pilar García
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

5.  Discovery and Biochemical Characterization of PlyP56, PlyN74, and PlyTB40-Bacillus Specific Endolysins.

Authors:  Irina Etobayeva; Sara B Linden; Farhang Alem; Laith Harb; Lucas Rizkalla; Philip D Mosier; Allison A Johnson; Louise Temple; Ramin M Hakami; Daniel C Nelson
Journal:  Viruses       Date:  2018-05-21       Impact factor: 5.048

Review 6.  Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.

Authors:  Hugo Oliveira; Carlos São-José; Joana Azeredo
Journal:  Viruses       Date:  2018-05-29       Impact factor: 5.048

7.  Use of a bacteriophage lysin to identify a novel target for antimicrobial development.

Authors:  Raymond Schuch; Adam J Pelzek; Assaf Raz; Chad W Euler; Patricia A Ryan; Benjamin Y Winer; Andrew Farnsworth; Shyam S Bhaskaran; C Erec Stebbins; Yong Xu; Adrienne Clifford; David J Bearss; Hariprasad Vankayalapati; Allan R Goldberg; Vincent A Fischetti
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

8.  Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.

Authors:  Raymond Schuch; Han M Lee; Brent C Schneider; Karen L Sauve; Christina Law; Babar K Khan; Jimmy A Rotolo; Yuki Horiuchi; Daniel E Couto; Assaf Raz; Vincent A Fischetti; David B Huang; Robert C Nowinski; Michael Wittekind
Journal:  J Infect Dis       Date:  2013-11-28       Impact factor: 5.226

Review 9.  Phages preying on Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis: past, present and future.

Authors:  Annika Gillis; Jacques Mahillon
Journal:  Viruses       Date:  2014-07-09       Impact factor: 5.048

10.  Genomic characterization of three novel Basilisk-like phages infecting Bacillus anthracis.

Authors:  J Farlow; D Bolkvadze; L Leshkasheli; I Kusradze; A Kotorashvili; N Kotaria; N Balarjishvili; L Kvachadze; M Nikolich; M Kutateladze
Journal:  BMC Genomics       Date:  2018-09-18       Impact factor: 3.969

View more
  11 in total

1.  Identification and characterization of novel endolysins targeting Gardnerella vaginalis biofilms to treat bacterial vaginosis.

Authors:  Sara Arroyo-Moreno; Matthew Cummings; David B Corcoran; Aidan Coffey; Ronan R McCarthy
Journal:  NPJ Biofilms Microbiomes       Date:  2022-04-19       Impact factor: 8.462

Review 2.  The Bacillus anthracis Cell Envelope: Composition, Physiological Role, and Clinical Relevance.

Authors:  Alice Chateau; Sander E Van der Verren; Han Remaut; Antonella Fioravanti
Journal:  Microorganisms       Date:  2020-11-26

Review 3.  Phage therapy as a revolutionary medicine against Gram-positive bacterial infections.

Authors:  Archana Loganathan; Prasanth Manohar; Kandasamy Eniyan; C S VinodKumar; Sebastian Leptihn; Ramesh Nachimuthu
Journal:  Beni Suef Univ J Basic Appl Sci       Date:  2021-08-28

Review 4.  Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance.

Authors:  Raymond Schuch; Cara Cassino; Xavier Vila-Farres
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

5.  A Lysozyme Murein Hydrolase with Broad-Spectrum Antibacterial Activity from Enterobacter Phage myPSH1140.

Authors:  Nachimuthu Ramesh; Prasanth Manohar; Kandasamy Eniyan; Loganathan Archana; Sudarsanan Athira; Belinda Loh; Long Ma; Sebastian Leptihn
Journal:  Antimicrob Agents Chemother       Date:  2022-08-11       Impact factor: 5.938

6.  Isolation and Characterization of Bacillus cereus Phage vB_BceP-DLc1 Reveals the Largest Member of the Φ29-Like Phages.

Authors:  Chun Li; Xiaoming Yuan; Na Li; Juan Wang; Shubo Yu; Haiyan Zeng; Jumei Zhang; Qingping Wu; Yu Ding
Journal:  Microorganisms       Date:  2020-11-07

7.  Characterization of PlyB221 and PlyP32, Two Novel Endolysins Encoded by Phages Preying on the Bacillus cereus Group.

Authors:  Audrey Leprince; Manon Nuytten; Annika Gillis; Jacques Mahillon
Journal:  Viruses       Date:  2020-09-21       Impact factor: 5.048

8.  The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.

Authors:  Yuyu Yuan; Xiaoyu Li; Lili Wang; Gen Li; Cong Cong; Ruihua Li; Huijing Cui; Bilal Murtaza; Yongping Xu
Journal:  Microb Biotechnol       Date:  2020-06-10       Impact factor: 5.813

9.  Optimization of Propidium Monoazide qPCR (Viability-qPCR) to Quantify the Killing by the Gardnerella-Specific Endolysin PM-477, Directly in Vaginal Samples from Women with Bacterial Vaginosis.

Authors:  Agnieszka Latka; Leen Van Simaey; Marijke Reynders; Piet Cools; Tess Rogier; Barbara Lebbe; Lorenzo Corsini; Christine Landlinger; Mario Vaneechoutte
Journal:  Antibiotics (Basel)       Date:  2022-01-15

Review 10.  Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application.

Authors:  Katarzyna M Danis-Wlodarczyk; Daniel J Wozniak; Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2021-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.